Is Moderna Stock Outperforming the Dow?

Moderna has outperformed the Dow over the past year, yet Wall Street analysts maintain a cautious outlook on the stock’s prospects.

MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot

Shares of Moderna MRNA rose about 4% on Friday after the company announced that the EMA’s Committee for Medicinal Products ...

Pfizer vs Moderna: Which pharma stock has more upside?

They aren't just "pandemic stocks." ...
Nasdaq

MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS

Moderna MRNA announced that it entered a settlement agreement resolving a patent dispute with Genevant Sciences, a subsidiary of Roivant Sciences ROIV, and Arbutus Biopharma ABUS. With this deal, ...